[Photo] 'Dreaming of a World Without COVID-19...'

Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus disease (COVID-19). The domestic bio venture company, Engicam Life Sciences, has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the New Year 2021, a researcher is fully engaged in COVID-19 treatment research at Engicam Life Sciences Central Research Institute in Jecheon, Chungbuk./Reporter Kang Jinhyung aymsdream@

This content was produced with the assistance of AI translation services.